v3.26.1
Nature of Operations and Summary of Significant Accounting Policies (Tables)
 6 Months Ended
Jun. 30, 2026
Accounting Policies [Abstract]  
Schedule of Franchisor Disclosure
The following table summarizes the number of clinics in operation under franchise agreements and as company-owned or managed clinics for the three and six months ended June 30, 2026 and 2025:
Three Months Ended
June 30,		Six Months Ended
June 30,
Franchised clinics:2026202520262025
Clinics open at the beginning of the period868 847 885 842 
Opened during the period5 7 8 12 
Acquired during the period29 37 29 39 
Closed during the period(6)(6)(26)(8)
Clinics in operation at the end of the period896 885 896 885 
Three Months Ended
June 30,		Six Months Ended
June 30,
Company-owned or managed clinics:2026202520262025
Clinics open at the beginning of the period75 122 75 125 
Sold during the period(29)(37)(29)(39)
Closed during the period(1)(3)(1)(4)
Clinics in operation at the end of the period45 82 45 82 
Total clinics in operation at the end of the period941 967 941 967 
Clinic licenses sold but not yet developed at the end of the period52 92 52 92 
Future clinic licenses subject to executed letters of intent at the end of the period58 60 58 60 
Schedule of Variable Interest Entities
VIE net income (including the management fee) for the three and six months ended June 30, 2026 and 2025, respectively, is included in Income from discontinued operations before income tax expense and Income tax (benefit) expense from discontinued operations in the condensed consolidated statements of operations as follows:
Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Income from discontinued operations before income tax$1,872,609 $427,212 $2,598,648 $814,499 
Income tax (benefit) expense from discontinued operations(2,559)100,201 179,810 203,613 
Net income$1,875,168 $327,011 $2,418,838 $610,886 
The carrying amount of the VIEs’ assets and liabilities is included in discontinued operations as of June 30, 2026 and December 31, 2025 in the condensed consolidated balance sheets as follows:
June 30,
2026		December 31,
2025
Discontinued operations current assets$994,138 $994,138 
Discontinued operations current liabilities3,219,152 6,079,903 
Schedule of Allowance for Credit Losses
The following table provides a reconciliation of the activity related to our allowance for credit losses:
Allowance for
Credit Losses
Balance at December 31, 2024$220,893 
  Bad debt expense recognized during the year286,232 
  Write-off of uncollectible amounts(77,638)
Balance at December 31, 2025$429,487 
  Bad debt expense recognized during the period 122,823 
  Write-off of uncollectible amounts(75,920)
Balance at June 30, 2026$476,390 
Schedule of Impairment Losses and Disposal Gains and Losses Recorded in Income from Discontinued Operations As a result of our evaluation of the recoverability of the carrying value of the assets and liabilities held for sale relative to the agreed upon sales prices or the clinics’ estimated fair values, we recorded an estimated net loss on disposal, which is included in Income from discontinued operations before income tax expense in the condensed consolidated statements of operations as follows:
Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Net loss on disposition or impairment related to discontinued operations$1,408,035 $439,831 $1,816,267 $1,422,765 
The following table shows a reconciliation of our impairment and disposal losses recorded in Income from discontinued operations before income tax expense for the three and six months ended June 30, 2026 and 2025:
Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Impairment on assets held for sale
Assets held for sale$1,408,035 $439,831 $1,816,267 $1,422,765 
Loss (gain) on disposal of assets other than by sale
Property and equipment, net1,734 257,922 2,550 267,164 
Operating lease right-of-use asset(281,122)233,695 (274,638)425,778 
(Gain) loss on the sale of assets(312,181)821,046 (349,949)770,145 
Total net loss on disposition or impairment related to discontinued operations$816,466 $1,752,494 $1,194,230 $2,885,852 
The key components of Net income from discontinued operations that were included in our condensed consolidated statements of operations are as follows:
Three Months Ended June 30,Six Months Ended June 30,
2026202520262025
Revenues:
Revenues from company-owned or managed clinics$7,591,917 $16,642,013 $16,946,108 $33,548,363 
Total revenues7,591,917 16,642,013 16,946,108 33,548,363 
Cost of revenues:
IT cost of revenues4,906 5,551 11,087 11,723 
Total cost of revenues4,906 5,551 11,087 11,723 
Selling and marketing expenses733,897 1,825,654 1,741,199 3,718,400 
Depreciation and amortization1,690 17,120 9,447 43,505 
General and administrative expenses5,133,125 11,857,995 12,697,626 24,128,217 
Total selling, general and administrative expenses5,868,712 13,700,769 14,448,272 27,890,122 
Net loss on disposition or impairment from discontinued operations816,466 1,752,494 1,194,230 2,885,852 
Income from discontinued operations901,833 1,183,199 1,292,519 2,760,666 
Other expense, net44 — 12,017 238 
Income before income tax expense901,789 1,183,199 1,280,502 2,760,428 
Income tax (benefit) expense from discontinued operations(2,559)100,201 179,810 203,613 
Net income from discontinued operations$904,348 $1,082,998 $1,100,692 $2,556,815 
The following table summarizes the major classes of assets and liabilities of discontinued operations that were included in our condensed consolidated balance sheets:
June 30,
2026		December 31,
2025
ASSETS
Restricted cash$824,163 $— 
Accounts receivable181,144 315,201 
Prepaid expenses and other current assets253,803 581,504 
Assets held for sale, net of valuation allowance12,280,539 20,051,965 
Property and equipment, net— 67,779 
Deferred tax assets (attributable to VIEs)994,138 994,138 
Deposits and other assets227,194 235,731 
Total assets, discontinued operations$14,760,981 $22,246,318 
LIABILITIES
Accounts payable$26,981 $83,503 
Accrued expenses2,870,060 2,519,433 
Payroll liabilities ($0.1 million and $0.6 million attributable to VIEs, respectively)
345,312 988,865 
Operating lease liability, current portion5,424 651,844 
Other current liabilities ($0.8 million attributable to VIEs)
1,580,646 756,483 
Liabilities to be disposed of ($2.3 million and $4.7 million attributable to VIEs, respectively)
9,351,816 16,368,318 
Total liabilities, discontinued operations$14,180,239 $21,368,446 
The key components of cash flows from discontinued operations are as follows:
Six Months Ended June 30,
20262025
Significant operating and investing non-cash items:
Depreciation and amortization$9,447 $43,505 
Net loss on disposition or impairment
1,194,230 2,885,852 
Capital expenditures:
Purchase of property and equipment15,753 73,535 
The principal components of the held for sale assets and liabilities to be disposed of as of June 30, 2026 and December 31, 2025 were as follows:
June 30, 2026December 31, 2025
ASSETS
Property and equipment, net
$3,139,305 $4,497,545 
Operating lease right-of-use asset9,313,107 14,111,081 
Intangible assets, net4,195,177 4,288,265 
Goodwill2,927,597 3,482,718 
Valuation allowance(7,294,647)(6,327,644)
Total assets held for sale, net$12,280,539 $20,051,965 
LIABILITIES
Operating lease liability, current and non-current$6,422,252 $11,065,542 
Deferred revenue from company-owned or managed clinics2,929,564 5,302,776 
Total liabilities to be disposed of$9,351,816 $16,368,318 
Schedule of Earnings (loss) per Common Share
Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Net (loss) income from continuing operations$(251,327)$(989,635)$851,464 $(1,495,656)
Net income from discontinued operations904,348 1,082,998 1,100,692 2,556,815 
Net income$653,021 $93,363 $1,952,156 $1,061,159 
Weighted average common shares outstanding - basic14,244,929 15,326,317 14,213,195 15,256,755 
Effect of dilutive securities:
Unvested restricted stock and stock options2,064 74,091 3,037 71,443 
Weighted average common shares outstanding - diluted14,246,993 15,400,408 14,216,232 15,328,198 
(Loss) income earnings per share:
Basic (loss) income earnings per share:
Continuing operations$(0.01)$(0.06)$0.06 $(0.10)
Discontinued operations0.06 0.07 0.08 0.17 
Net income per basic share$0.05 $0.01 $0.14 $0.07 
Diluted (loss) income earnings per share
Continuing operations$(0.01)$(0.06)$0.06 $(0.10)
Discontinued operations0.06 0.07 0.08 0.17 
Net income per diluted share$0.05 $0.01 $0.14 $0.07 
The following common stock equivalents were excluded from the computation of diluted earnings (loss) per share for the periods presented because including them would have been antidilutive:
Three Months Ended
June 30,		Six Months Ended
June 30,
2026202520262025
Stock options49,890 81,153 50,978 76,825